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BACKGROUND: The risk of developing red blood cell
(RBC) transfusion–associated necrotizing enterocolitis
(TANEC) in preterm infants has recently been
emphasized. Our aim was to assess changes in cytokine
serum levels after RBC transfusions in a cohort of very
preterm infants to evaluate their possible
proinflammatory effect.
STUDY DESIGN AND METHODS: We carried out a
prospective observational study. One transfusion event
was studied in infants less than 32 weeks’ gestation and
more than 7 days old (n5 20) admitted to a tertiary
neonatal intensive care unit. Interleukin (IL)21b, IL-6, IL-
8, tumor necrosis factor-a, interferon-c (IFN-c), IL-17,
monocyte chemoattractant protein-1 (MCP-1), interferon-
c–induced protein 10 (IP-10), intracellular adhesion
molecule-1 (ICAM-1), and vascular cell adhesion
molecule serum levels were measured in enrolled
patients within 120 minutes before (T0) the RBC
transfusion and then within 120 minutes (T1), 126 3
hours (T2), 246 6 hours (T3), and 486 6 hours (T4) after
the end of RBC transfusion.
RESULTS: Infants received 19.86 3.0 mL of RBCs at
the mean age of 506 18 days. Their hematocrit level
increased from 24.16 1.2% to 39.46 2.9%. IL-1b, IL-8,
IFN-c, IL-17, MCP-1, IP-10, and ICAM-1 increased
significantly after RBC transfusions.
CONCLUSION: Proinflammatory cytokines are
increased after RBC transfusion. These findings may
contribute to explaining the pathogenesis of TANEC and
suggest the opportunity of adopting wise transfusion
guidelines that would help to avoid detrimental risks of
transfusion-related immunomodulation and of
undertransfusion.
P
reterm infants are at high risk of becoming rapid-
ly anemic due to a combination of frequent labo-
ratory blood sampling and their immature
hematopoietic system.1,2 Therefore, from 80% to
90% of extremely low birthweight infants receive one or
more transfusions of red blood cells (RBCs).3,4 The risks
and benefits of RBC transfusions for preterm infants
remain unclear; guidelines for transfusing RBCs are con-
troversial and practices vary greatly. Studies on liberal5 or
restrictive6 policies of RBC transfusions have provided
inconclusive and contradictory results, although one
meta-analysis suggests that restrictive RBC transfusion
may be utilized without increasing short-term neonatal
morbidities.4
It has been reported that RBC transfusions can
increase the risk of developing multifactorial disease such
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as bronchopulmonary dysplasia (BPD)7-9 and retinopathy
of prematurity (ROP).10,11 However, their pathogenetic
role has been mainly emphasized for necrotizing entero-
colitis (NEC), 12,13 which is the most common neonatal
gastrointestinal complication in preterm infants.14 In fact,
several cases of NEC develop after RBC transfusions,15-18
and 25% to 30% of these occur within 48hours after the
transfusion.13,19 It has been reported that RBC transfu-
sions increase significantly (odds ratio, 2.3; 95% confi-
dence interval, 1.2-4.2) the risk of developing transfusion
associated-NEC (TANEC),20 while a strict policy of with-
holding feeds during RBC transfusions seems to decrease
it.21 Another article suggests that severe anemia, but not
RBC transfusion, was associated with an increased risk of
NEC.22
Despite these findings, the pathogenesis of TANEC is
unknown. Previous studies have investigated the possible
inflammatory effect of RBC transfusions mediated by the
increase in proinflammatory cytokine serum values23,24
and iron25 in transfused preterm infants, but their results
were contradictory and inconclusive.
In light of previous data, we have hypothesized that
RBC transfusions can induce a proinflammatory response
in treated preterm infants and to test this hypothesis we
assessed changes in serum levels of interleukin (IL)1b,
IL-6, IL-8, tumor necrosis factor-a (TNF-a), interferon-c
(IFN- c), IL-17, monocyte chemoattractant protein-1
(MCP-1), IFN-c–induced protein 10 (IP-10), intracellular
adhesion molecule-1 (ICAM-1), and vascular cell adhesion
molecule (VCAM) during the 48 hours after RBC transfu-
sions in a cohort of very preterm infants.
MATERIALS AND METHODS
Patient population
This prospective center-based study was carried out at the
neonatal intensive care unit of Careggi University Hospital
of Florence. The study was approved by the Tuscany pedi-
atric ethics committee. Infants with gestational age of less
than 32 weeks and postnatal age of more than 7 days were
enrolled in the study if they needed RBC transfusions
according to the guidelines of the Italian Society of Neo-
natology26 and after parental informed consent was given.
Exclusion criteria were major congenital malformations,
inherited metabolic diseases, previous RBC transfusions
during the 4weeks before the study, and suspected or
blood culture–proven sepsis or steroidal treatment during
the 7days before and the 2days after the transfusion
(because these conditions could affect the cytokine
profile).
Study design
Serum levels of IL-1b, IL-6, IL-8, TNF-a, IFN-c, IL-17,
MCP-1, IP-10, ICAM-1, and VCAM were measured in
enrolled patients within 120 minutes before (T0) the RBC
transfusion, and then within 120 minutes (T1), 126 3
hours (T2), 246 6 hours (T3), and 486 6 hours after the
end of RBC transfusion. Cytokines were determined in
whole blood samples (150 mL) collected in tube from heel
puncture, or in syringe from vein puncture, contemporary
to sampling for routine blood gas analyses or other bio-
chemical tests as to avoid further withdrawals. Whole
blood samples were centrifuged at 1123 g at room tem-
perature for 15 minutes. The supernatant was then col-
lected and stored at 2808C until measurements were
made using Luminex technology (Bio-Plex 200 system,
Bio-Rad) according to the manufacturer’s instructions.
The concentration of IL-1b, IL-6, IL-8, TNF-a, IFN-c, IL-
17, MCP-1, and IP-10 was expressed as pg/mL, while that
of ICAM-1 and VCAM was expressed as ng/mL. The same
method was used for measuring studied cytokines in all
RBC donor units.
RBC transfusion procedure
RBCs were transfused via a peripheral vein at the infusion
rate of 5 mL/kg/hr and to avoid fluid overload the enteral
and/or parenteral nutrition was generally decreased to
50%, without changes during the transfusion. The volume
of RBCs needed by each patient was calculated using the
formula 803weight (kg)3 (desired hematocrit [Hct] –
current Hct)/Hct of donor unit.
In each case adult leukoreduced RBCs stored in SAG-
M (adenine, 0.169 g/L; glucose, 9.0 g/L; mannitol, 5.25 g/
L; sodium chloride, 8.77 g/L) without further concentra-
tion by centrifugation, less than 1 week old, and within 2
hours of irradiation were used. Within 15 minutes before
the transfusion every RBC unit was studied to evaluate its
hemoglobin and Hct (ABL 735, Radiometer).
Clinical data
The following variables were recorded for each patient:
gestational age, birthweight, sex, antenatal steroids treat-
ment, type of delivery, venous umbilical pH, Apgar score
at 5 minutes, patients’ age at transfusion, pre- and post-
transfusion Hct, RBC transfused volume, age at transfu-
sion, occurrence of respiratory distress syndrome,
occurrence of noninvasive ventilation (high flow nasal
cannula, nasal continuous airway pressure, nasal inter-
mittent mandatory ventilation) and mechanical ventila-
tion (patient-triggered ventilation, high-frequency
oscillatory ventilation), occurrence of patent ductus arte-
riosus, intraventricular hemorrhage, periventricular leuko-
malacia, BPD, NEC, ROP, sepsis, and length of hospital
stay. Intraventricular hemorrhage was diagnosed and
staged according to the classification of Papile and col-
leagues,27 BPD was defined as oxygen requirements at 36
weeks of postconceptional age,28 NEC was diagnosed and
staged according to Bell’s criteria,29 ROP was diagnosed
and staged according to the current international
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classification,30 and sepsis was diagnosed when patients
developed clinical signs and symptoms associated with a
positive blood culture.
Statistical analysis
In planning our study, we calculated that a sample size of
at least 18 infants was required to detect a significant
increase of IL-1b from 0.756 0.75 to 0.956 0.75 (27%)
after the conclusion of the RBC transfusion (T1) with 80%
power at 0.05 level. Patients’ clinical characteristics were
described as mean and standard deviation (SD) or rate
and percentage and cytokine values as median and inter-
quartile range (IQR). Changes in cytokine pretransfusion
and posttransfusion serum levels were assessed by using
the Wilcoxon signed rank test as they were not normally
distributed. All statistical tests were two-sided, and p val-
ues of not more than 0.05 were considered to be
significant.
In addition, to investigate the possibility that effects
of RBC transfusion on cytokine serum levels could be
affected by patients’ gestational age and anemia severity
groups of infants who were born at less than or 28 or more
weeks of gestation, who were transfused at Hct level of
less than or 24% or more, and who had a posttransfu-
sional increase of Hct level of less than or 15% or more
were compared.
RESULTS
We studied 20 preterm infants who received 19.86 3.0 mL
of RBCs at the mean age of 506 18 days. Their Hct level
increased from 24.16 1.2% to 39.46 2.9%. The mean age
of RBC unit was 3.26 0.9 days. The baseline clinical char-
acteristics of infants are reported in Table 1.
We found a significant increase in IL-1b from baseline
to T3 value (p5 0.04); IL-8 from baseline to T1 value
TABLE 1. Clinical characteristics of infants*
Clinical characteristics n 5 20
Gestational age (weeks) 27.7 6 2.4
Birthweight (g) 889 6 147
Male sex 10 (50)
Antenatal steroids 18 (90)
Cesarean section 19 (95)
Venous umbilical pH 7.30 6 0.09
Apgar score at 5 min 8 (8-9)
RDS 10 (50)
Noninvasive support 17 (85)
Mechanical ventilation 6 (30)
PDA 12 (60)
IVH 2 (10)
Grade 3 0 (0)
PVL 0 (0)
BPD 5 (25)
NEC 0 (0)
ROP 2 (10)
Sepsis 6 (30)
Mortality 0 (0)
Hospital stay (day) 76 6 25
Respiratory support at enrollment 5 (25)
N-IMV 0 (0)
NCPAP 4 (20)
HFNC 1 (5)
FiO2 at enrollment 0.22 6 0.01
* Data are reported as mean 6 (SD) or rate (%).
HFNC 5 high-flow nasal cannula; IVH 5 intraventricular hemor-
rhage; NCPAP 5 nasal continuous airway pressure; NEC 5
necrotizing enterocolitis; N-IMV 5 noninvasive mechanical ven-
tilation; PDA 5 patent ductus arteriosus; PVL 5 periventricular
leukomalacia; RDS 5 respiratory distress syndrome.
TABLE 2. Serum concentrations of cytokines and adhesion molecules after RBC transfusion*
Cytokine or adhesion molecule T0 T1 T2 T3 T4
IL-1b (pg/mL) 0.72
(0.63-1.30)
0.91
(0.63-1.34)
0.89
(0.58-1.58)
1.05†
(0.80-1.52)
0.93
(0.63-1.32)
IL-6 (pg/mL) 1.99
(1.36-4.24)
2.45
(1.37-4.40)
2.27
(1.13-3.87)
2.87
(1.67-4.66)
2.13
(0.98-4.34)
IL-8 (pg/mL) 14.06
(7.03-24.10)
14.61†
(8.35-26.91)
11.08
(6.93-21.50)
19.18
(12.03-29.80)
11.32
(8.05-26.30)
TNF-a (pg/mL) 3.68
(1.53-5.36)
3.83
(1.94-5.52)
3.36
(1.87-4.95)
4.17
(1.98-4.96)
3.94
(1.60-5.77)
IFN-c (pg/mL) 9.39
(4.97-1.95)
10.52
(5.98-14.81)
11.09†
(5.20-12.67)
11.66‡
(9.04-17.12)
13.38†
(8.54-16.54)
IL-17 (pg/mL) 3.06
(2.68-4.01)
4.53†
(3.94-6.18)
4.72†
(3.37-5.68)
4.09†
(2.98-5.39)
5.11‡
(3.29-7.40)
MCP-1 (pg/mL) 285.33
(204.97-330.31)
432.19‡
(385.43-488.06)
441.52‡
(306.41-611.75)
481.49‡
(363.92-617.27)
473.03‡
(363.32-570.28)
IP-10 (pg/mL) 102.71
(70.56-151.93)
109.20†
(101.37-147.90)
109.21†
(86.59-268.40)
115.14†
(83.41-256.89)
140.14†
(103.20-206.93)
ICAM (ng/mL) 492,92
(281.27-901.51)
388.79†
(245.28-771.49)
392.32
(204.95-970.22)
378.28
(226.74-1009.91)
417.79
(248.99-918.84)
VCAM (ng/mL) 969.92
(604.99-2561.74)
1066.77
(517.31-1867.49)
1120.33
(604.99-2471.21)
1469.00
(564.27-2636.81)
1661.43
(692.45-2286.18)
* Data are reported as median (IQR).
† p < 0.05.
‡ p < 0.001.
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(p5 0.04); IFN-c from baseline to T2 (p5 0.02), T3
(p< 0.001), and T4 (p5 0.05); IL-17 from baseline to T1
(p5 0.02), T3 (p5 0.03), and T4 (p< 0.001); MCP-1 from
baseline to T1 (p< 0.001), T2 (p< 0.001), T3 (p< 0.001),
and T4 (p< 0.001); and IP-10 from baseline to T1
(p< 0.01), T2 (p5 0.02), T3 (p< 0.01), and T4 (p< 0.01;
Table 2, Figs. 1 and 2). Changes of cytokine serum levels
were similar between groups of infants who were born
at less than or 28 or more weeks of gestation, who were
transfused at Hct level of less than or 24% or more, and
who had a posttransfusional increase of Hct level of less
than or 15% or more (unreported data). None of the stud-
ied cytokines were found in RBC donor units.
DISCUSSION
In this study we evaluated changes in serum levels of IL-
1b, IL-6, IL-8, TNF-a, IFN-c, IL-17, MCP-1, IP-10, ICAM-1,
and VCAM after RBC transfusions in preterm infants to
assess their potential proinflammatory effect and their
possible pathogenetic contribution to the development of
TANEC during the 48 hours after transfusions. We found
that IL-1b increased 24 hours after transfusions; IL-8 and
ICAM-1 increased 2hours after transfusions; while IFN-c,
IL-17, MCP-1, and IP-10 were increased throughout the
48-hour study period after transfusions. Thus, our findings
can contribute to explain the pathogenesis of TANEC,
although the correlation between RBC transfusions and
NEC is still debated,20-22 but also the reported association
between RBC transfusions and the development of BPD7-9
and ROP.10,11
Our results are in agreement with Keir and col-
leagues24 regarding the increase in IL-1b, IL-8, MCP-1,
and ICAM-1, but are in disagreement in terms of our
unchanged value of TNF-a and increased value of IFN-c.
Similarly, our results are in agreement with Locke and
coworkers23 in regard to unchanged values of IL-6 and
TNF-a, but are in disagreement regarding the increase in
Fig. 1. Changes of cytokine serum level after RBC transfusion. Median (IQR).
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IL-1b observed in our study. These differences can be
explained by several factors, such as the different study
period duration. We measured cytokine serum level four
times during the 48 hours after RBC transfusion, while in
previous studies they were evaluated only once after 123
or 2 to 424 hours. Second, we did not find any cytokines in
RBC donor units similarly to Locke and colleagues23 and
in disagreement with Keir and colleagues.24 These find-
ings might depend on the different age of RBC units at
transfusion that was shorter in our study (3.26 0.9 days)
than in the study by Keir and coworkers (median age, 23
days; range, 6-33days), although they did not find any
correlation between cytokine level and transfusion pack
age.24 Third, the blood pack store additive solution was
similar to ours in the study by Locke and coworkers (AS-5
Optisol, Terumo Corp.),23 but unreported in the study by
Keir and coworkers.24 Fourth, there are different methods
of cytokine measurement, the one in the study by Keir
and coworkers being similar to ours (Luminex technolo-
gy),24 but different in the study by Locke and coworkers
(sandwich immunoassay technique).23
The mechanisms by which RBC transfusion can
induce an increase in cytokine serum level can be
explained by the transfusion-related immunomodulation
(TRIM). In the clinical setting of an underlying inflamma-
tory condition, such as prematurity, RBC transfusions
may trigger immune cell activation and induce proinflam-
matory effects on endothelial, epithelial, and innate
immune system cells,24 thus promoting cytokine release.
In fact, although leukoreduction removes 99.9% of white
blood cells from transfusion units limiting TRIM,31 a sig-
nificant residual capacity for an immunomodulatory
effect might be mediated by bioactive substances, such as
non–transferrin-bound iron (NTBI) and unbound free
heme that continue to accumulate over time in micropar-
ticle and supernatant fractions, even after leukoreduc-
tion.24,32 It has been recently demonstrated that NTBI is
detectable in the transfusion packs in correlation with
their age, and its level is higher after transfusion and is
associated with an increase in oxidative stress in preterm
infants.25 It is noteworthy that NTBI oxidative stress can
promote inflammation through the up regulation of IL-1b,
IL-6, and IL-8.33,34 Moreover, free heme has also been
found to induce oxidative stress and the release of IL-835
and ICAM-1.36 Another underestimated potential mecha-
nism by which RBC transfusion can promote an increase
in cytokine serum level in transfused preterm infants is
the associated great variability in splanchnic tissue oxy-
genation that has been recently reported37 and that might
result in the production of free radicals and proinflamma-
tory cytokines triggered by ischemia–reperfusion injury of
intestinal tissue.
Increased serum levels of IL-1b, IL-8, IFN-c, MCP-1,
and IP-10 have been reported in preterm infants with
NEC38-40 and/or sepsis,41 while ICAM-1 and IL-17 have
never been studied in these clinical conditions. Nonethe-
less, our findings confirm24 that proinflammatory cyto-
kine concentrations can increase also in infants who
Fig. 2. Changes of MCP-1, IP-10, ICAM-1, and VCAM serum level after RBC transfusion. Median (IQR).
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receive RBC transfusions, although serum levels of IL-
1b,38,39,42 IL-8,40,41 IFN-c,38,40 MCP-1,38 and IP-1041 are
lower than those reported in infants with NEC or sepsis.
This might be partially due to the different methods used
for cytokines assessment,38-42 but, in our opinion, it sug-
gests that RBC transfusions can exert a proinflammatory
action less powerful than that induced by sepsis or NEC.
However, the combination of the contemporary and rath-
er prolonged increase in many proinflammatory cytokines
induced by RBC transfusions and in association with oth-
er risk factors such as prematurity, abnormal gut micro-
biota, and inadequate gastrointestinal perfusion can help
explain why several cases of TANEC have developed after
RBC transfusions13-16 and why 25% to 30% of these cases
occur within 48 hours of the transfusion.17,18
Strategies for limiting TRIM and detrimental proin-
flammatory effects of RBC transfusions have been investi-
gated, but the use of leukoreduction has given
contradictory clinical results.33 The recent ARIPI study failed
to demonstrate improved outcomes from the use of fresh
RBCs (7days old) in very low birthweight infants,43 and a
restrictive RBC transfusion policy has not been found to
decrease the risk of TANEC.44 Thus, care and caution in pre-
scribing RBC transfusions following shared guidelines
seems to be the most powerful approach to create benefits
without detrimental effects from RBC transfusional therapy.
The strengths of our study are that our patients were
investigated for 48 hours after RBC transfusion, which is
the riskiest period for TANEC development. Also, our
patients did not present contemporary potential proin-
flammatory confounding factors, such as infections or
mechanical ventilation. A limitation was that the use of
fresh RBC packs could have attenuated the cytokine up
regulation that might be more relevant when packs older
than ours are used.24-26 Moreover, the population size
might not allow to demonstrate a different effect of RBC
transfusions in more immature infants and in infants with
more severe anemia.
In conclusion, we found that RBC transfusions are
associated with an increase in IL-1b, IL-8, IFN-c, IL-17,
MCP-1, IP-10, and ICAM-1 during the 48hours after trans-
fusions. These findings can contribute to an explanation
of the pathogenesis of TANEC and suggest that physicians
should adopt wise transfusion guidelines which would
allow them to avoid the detrimental risks of either TRIM
or undertransfusion.
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